BRIEF-Ipsen and Lexicon sign licensing and commercialization agreement for telotristat etiprate
October 22, 2014 at 01:53 AM EDT
* Lexicon Pharmaceuticals and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate